Abstract

Background: The American Heart Association (AHA) proposed the concept of ideal cardiovascular health (CVH) to reduce the risk of cardiovascular mortality. However, the overall CVH status is still unsatisfactory. We attempted to contribute to AHA 2030 goals by identifying the relationship between CVH and non-cardiovascular diseases such as sarcopenia. Methods: We analyzed data on 3311 adults > 20 years of age from the NHANES 2011-2018. Sarcopenia was defined as the lowest for gender-specific sarcopenia index cut-off values. CVH was categorized as inadequate, average, or optimum. We used multinomial logistic regression to assess the association between CVH and sarcopenia. Results: This cohort study involving 3,311 adults > 20 years comprised 1329 females (42.4%). The number of intermediate or ideal and poor CVH participants was 1719 and 1592 with mean CVH score of 9.3 ± 0.1 and 5.43 ± 0.1, respectively. After adjusting for related confounding factors, intermediate or ideal CVH was associated with a risk reduction of sarcopenia than poor CVH (aOR: 0.39, 95% CI; 0.22-0.69, P < 0.001) and the risk of sarcopenia was significantly lower for each incremental increase of 1 in CVH metrics (aOR: 0.76, 95% CI: 0.70-0.83, P < 0.001). Moreover, if the number of ideal CVH metrics was > 5, the risk of sarcopenia decreased by up to 85% (aOR: 0.15, 95% CI: 0.06-0.38, P < 0.05). Conclusions: Our findings suggest a relationship between the CVH and the prevalence of sarcopenia in adults. Our analysis confirms that CVH extends beyond protection against cardiovascular disease. The results of our study can contribute to achieving the 2030 public health goal of achieving CVH for all, which may be supported by efforts to reduce the prevalence of sarcopenia.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call